MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Alliqua Biomedical Company Profile (NASDAQ:ALQA)

Consensus Ratings for Alliqua Biomedical (NASDAQ:ALQA) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.05 (196.12% upside)

Analysts' Ratings History for Alliqua Biomedical (NASDAQ:ALQA)
Show:
DateFirmActionRatingPrice TargetActions
5/11/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Northland SecuritiesLower Price TargetOutperform$7.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Craig HallumLower Price TargetBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016RBC CapitalLower Price TargetOutperform$6.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Chardan CapitalReiterated RatingBuy$4.25 -> $2.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015Cowen and CompanyInitiated CoverageOutperform$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Alliqua Biomedical (NASDAQ:ALQA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/10/2016Q116($0.25)($0.20)$4.99 million$4.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q4($0.28)($0.18)$5.30 million$4.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.29)($0.25)$5.44 million$5.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.30)($0.27)$2.85 million$3.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/14/2015Q115($0.34)($0.21)$2.37 million$2.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414($0.31)($0.34)$1.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q3 14($0.31)($0.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q214($0.41)($0.39)$1.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014($0.40)($0.73)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/24/2014Q313($0.23)($1.68)$0.40 million$0.47 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Alliqua Biomedical (NASDAQ:ALQA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.29)($0.28)($0.29)
Q2 20162($0.27)($0.26)($0.27)
Q3 20162($0.26)($0.24)($0.25)
Q4 20162($0.25)($0.23)($0.24)
Q1 20171($0.25)($0.25)($0.25)
Q2 20171($0.23)($0.23)($0.23)
Q3 20171($0.19)($0.19)($0.19)
Q4 20171($0.17)($0.17)($0.17)
(Data provided by Zacks Investment Research)
Dividend History for Alliqua Biomedical (NASDAQ:ALQA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Alliqua Biomedical (NASDAQ:ALQA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
11/9/2015Brian M PosnerCFOBuy5,000$3.04$15,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Bradford BartonCOOBuy5,000$2.97$14,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015David Ian JohnsonCEOBuy8,650$2.92$25,258.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Jerome B ZeldisDirectorBuy14,000$2.91$40,740.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Pellegrino PionatiInsiderBuy10,000$2.95$29,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/10/2015Brian M PosnerCFOBuy2,500$5.02$12,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Bradford BartonCOOBuy3,000$5.25$15,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2015David Ian JohnsonCEOBuy10,000$4.65$46,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Brian M PosnerCFOBuy2,500$4.34$10,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2015Corp /De/ CelgeneMajor ShareholderBuy659,340$4.55$2,999,997.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Brian M PosnerCFOBuy2,000$4.94$9,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Brian M PosnerCFOBuy3,000$6.92$20,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2014Corp /De/ CelgeneMajor ShareholderBuy714,286$7.00$5,000,002.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2013Kenneth L LondonerDirectorBuy219,500$0.07$15,365.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Alliqua Biomedical (NASDAQ:ALQA)
DateHeadline
06/28/16 07:41 AMCovering the Bases on Alliqua BioMedical, Inc. (NASDAQ:ALQA): Where is the Stock Going? - Press Telegraph
06/27/16 02:48 PMStock Volatility in Review: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Engelwood Daily
06/26/16 07:27 AMHow Many Alliqua Biomedical Inc (NASDAQ:ALQA)'s Analysts Are Bearish? - Engelwood Daily
06/25/16 02:26 PMAlliqua Biomedical DE (NASDAQ:ALQA) Sellers Covered 17.25% of Their Shorts - Engelwood Daily
06/24/16 02:26 PMShare Volatility Check for: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Press Telegraph
06/23/16 10:16 AMStrong Buy Calls Count For Alliqua BioMedical, Inc. (NASDAQ:ALQA) At 5 - Investor Newswire
06/21/16 11:46 AMETF’s with exposure to Alliqua BioMedical, Inc. : June 21, 2016 -
06/07/16 04:27 PMETF’s with exposure to Alliqua BioMedical, Inc. : June 7, 2016 -
06/06/16 06:31 AMALLIQUA BIOMEDICAL, INC. Files SEC form 8-K, Other Events -
06/02/16 11:05 AMStock Review and Earnings Check on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - HNN - Stock Review and Earnings Check on Alliqua BioMedical, Inc. (NASDAQ:ALQA)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Alliqua BioMedical, Inc. (NASDAQ:ALQA) to report quarterly EPS of $-0.24. The company's next earnings report is expected to be published ...and more »
05/31/16 02:27 PMShare Rating Focus on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - HNN - Share Rating Focus on Alliqua BioMedical, Inc. (NASDAQ:ALQA)HNNThis stock research may entail following what professional equity analysts think about the company. Presently, Wall Street analysts have given a consensus stock rating of 1 on shares of Alliqua BioMedical, Inc. (NASDAQ:ALQA). Covering analysts will ...and more »
05/30/16 02:04 PMPerformance at a Glance on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - HNN - Performance at a Glance on Alliqua BioMedical, Inc. (NASDAQ:ALQA)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how Alliqua BioMedical, Inc. (NASDAQ:ALQA)'s stock has performed at various points in its past. Currently ...How Many Alliqua Biomedical Inc (NASDAQ:ALQA)'s Analysts Are Bullish?The PostZeke Capital Advisors Exits Position in Alliqua Biomedical Inc (ALQA)Market DigestAlliqua BioMedical, Inc. (NASDAQ:ALQA) Quarterly EPS From Continuing Operations Stands At $-0.2815Markets Dailyall 5 news articles »
05/19/16 05:55 PMETF’s with exposure to Alliqua BioMedical, Inc. : May 19, 2016 -
05/18/16 12:17 PMAlliqua BioMedical, Inc. :ALQA-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/16/16 07:02 AMAlliqua BioMedical, Inc. to Attend Craig-Hallum Institutional Investor Conference - [at noodls] - YARDLEY, Pa., May 16, 2016 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (NASDAQ:ALQA) ('Alliqua' or 'the Company'), a provider of advanced wound care products, today announced that David Johnson, Chief ...
05/10/16 06:10 AMAlliqua reports 1Q loss -
05/10/16 06:08 AMAlliqua BioMedical, Inc. Reports First Quarter Financial Results - [at noodls] - Revenue Growth of 120% year-over-year; Reaffirms Fiscal Year 2016 Guidance YARDLEY, Pa., May 10, 2016 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ('Alliqua' or 'the Company'), a provider ...
05/10/16 06:07 AMQ1 2016 Alliqua BioMedical Inc Earnings Release - Before Market Open -
05/06/16 01:33 PMALLIQUA BIOMEDICAL, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Change in Directors -
02/23/16 07:10 AMAlliqua reports 4Q loss -
02/23/16 06:07 AMQ4 2015 Alliqua BioMedical Inc Earnings Release - Before Market Open -
02/23/16 06:00 AMAlliqua BioMedical, Inc. Reports Fourth Quarter and Fiscal Year 2015 Financial Results - [GlobeNewswire] - YARDLEY, Pa., Feb. 23, 2016-- Alliqua BioMedical, Inc., a provider of advanced wound care products, today announced financial results for the fourth quarter and fiscal year ended December 31, 2015.. Total ...
02/19/16 06:46 AMALLIQUA BIOMEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial State -
02/14/16 02:00 PMAlliqua Biomedical DE (NASDAQ:ALQA) Shorts Decreased by 22.56% After Short Covering - fdanewsalert.com - Alliqua Biomedical DE (NASDAQ:ALQA) Shorts Decreased by 22.56% After Short Coveringfdanewsalert.comOut of 6 analysts covering Alliqua Biomedical (NASDAQ:ALQA), 6 rate it “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Alliqua Biomedical was the topic in 5 analyst reports since August 19, 2015 according to StockzIntelligence Inc ...Zacks: Analysts Expect Alliqua Biomedical Inc (NASDAQ:ALQA) Will Announce Earnings of -$0.27 Per ShareThe Vista Voiceall 2 news articles »
02/10/16 06:30 AMAlliqua BioMedical to Present at Upcoming Investor Conferences - [GlobeNewswire] - LANGHORNE, Pa, Feb. 10, 2016-- Alliqua BioMedical, Inc., today announced that company management will participate in the following investor conferences:. The 2016 RBC Capital Markets' Global Healthcare ...
02/09/16 06:30 AMAlliqua BioMedical, Inc. to Announce Fourth Quarter and Fiscal Year 2015 Results on February 23rd - [GlobeNewswire] - LANGHORNE, Pa., Feb. 09, 2016-- Alliqua BioMedical, Inc., a provider of advanced wound care products, today announced plans to release fourth quarter and fiscal year 2015 financial results before the market ...
02/07/16 01:31 PMAlliqua Biomedical DE (NASDAQ:ALQA) Short Interest Increased By 68.9% - fdanewsalert.com - Alliqua Biomedical DE (NASDAQ:ALQA) Short Interest Increased By 68.9%fdanewsalert.comThe short interest to Alliqua Biomedical DE's float is 2.93%. The stock is down 3.09% or $0.05 after the news, hitting $1.57 per share. About 4,320 shares traded hands. Alliqua Biomedical Inc (NASDAQ:ALQA) has declined 69.72% since July 1, 2015 and is ...
02/04/16 02:00 PMAlliqua's UltraMIST® System Honored With GOOD DESIGN Award - LANGHORNE, Pa., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua" or "the Company"), today announced that its UltraMIST ® Ultrasound Healing Therapy System received a GOOD DESIGN® Award. The GOOD DESIGN Awards are ...
02/04/16 06:30 AMAlliqua’s UltraMIST® System Honored With GOOD DESIGN Award - [GlobeNewswire] - LANGHORNE, Pa., Feb. 04, 2016-- Alliqua BioMedical, Inc., today announced that its UltraMIST ® Ultrasound Healing Therapy System received a GOOD DESIGN ® Award. The GOOD DESIGN Awards are presented by ...
02/03/16 01:27 PMMid Day Alert: Alliqua Biomedical Inc(NASDAQ:ALQA), Oclaro, Inc.(NASDAQ:OCLR), Banco Bradesco SA (ADR ... - Market News Call - Mid Day Alert: Alliqua Biomedical Inc(NASDAQ:ALQA), Oclaro, Inc.(NASDAQ:OCLR), Banco Bradesco SA (ADR ...Market News CallAlliqua Biomedical Inc(NASDAQ:ALQA)'s shares fell 6.43% to $1.60 in the early hour. The company, on Jan. 28, 2016, announced that following the completion of Human Longevity, Inc.'s (“HLI”) planned purchase of LifebankUSA and other select assets from ...
01/30/16 01:04 PMEarnings Surprise in Focus: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Investor Newswire - Earnings Surprise in Focus: Alliqua BioMedical, Inc. (NASDAQ:ALQA)Investor NewswireFor the most recent quarter, Alliqua BioMedical, Inc. (NASDAQ:ALQA) reported earnings per share of $-0.25 for the fiscal period ending on 2015-09-30, an earnings surprise factor of 13.79%. The actual number was $0.04 away from the brokerage firm ...and more »
01/28/16 07:22 AMAlliqua Biomedical Announces Partnership With Human Longevity Inc., Under Existing Licensing Agreement - [at noodls] - Future Collaboration Focused on Developing Differentiated and Novel HCTP Technologies LANGHORNE, Pa., Jan. 28, 2016 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ('Alliqua' or 'the Company'), ...
01/28/16 07:02 AMALLIQUA BIOMEDICAL, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
01/27/16 12:42 PMAlliqua BioMedical Announces Agreement With HealthTrust - GlobeNewswire (press release) - Alliqua BioMedical Announces Agreement With HealthTrustGlobeNewswire (press release)LANGHORNE, Pa., Jan. 27, 2016 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announces that it has signed a national group purchasing agreement with ...
01/27/16 06:34 AMAlliqua BioMedical Announces Agreement With HealthTrust - [at noodls] - LANGHORNE, Pa., Jan. 27, 2016 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ('Alliqua' or 'the Company'), a provider of advanced wound care products, today announces that it has signed a national ...
01/27/16 06:34 AM7:34 am Alliqua has signed an agreement with HealthTrust -
01/19/16 11:50 AMAnalysts Issue Earnings Forecast For Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Investor Newswire - Analysts Issue Earnings Forecast For Alliqua BioMedical, Inc. (NASDAQ:ALQA)Investor NewswireAccording to analysts surveyed by Zacks Research, Alliqua BioMedical, Inc. (NASDAQ:ALQA) is expected to post earnings of $-0.2 per share for its most recent quarter. The company is set to release its earnings around 2016-02-23. Since the same set of ...and more »
12/18/15 08:44 AMAlliqua BioMedical, Inc. Earnings Analysis: Q3, 2015 By the Numbers -
12/08/15 12:17 PMALLIQUA BIOMEDICAL, INC. Financials -
11/12/15 08:02 AMALLIQUA BIOMEDICAL, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
11/09/15 07:06 AMAlliqua BioMedical, Inc. to Attend November Healthcare Conferences - [at noodls] - LANGHORNE, Pa., Nov. 9, 2015 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ('Alliqua' or 'the Company'), a provider of advanced wound care products, today announced that David Johnson, Chief ...
11/05/15 09:06 AMAlliqua reports 3Q loss -
11/05/15 06:20 AMAlliqua BioMedical, Inc. Reports Third Quarter Financial Results - [at noodls] - Revenue Growth of 236% year-over-year in Q3; Gross Margin Increases to 67% LANGHORNE, Pa., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ('Alliqua' or 'the Company'), a provider ...
11/05/15 06:16 AMALLIQUA BIOMEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and -
11/05/15 06:07 AMQ3 2015 Alliqua BioMedical Inc Earnings Release - Before Market Open -
10/12/15 07:25 AMAlliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2015 Results on November 5th - [at noodls] - LANGHORNE, Pa., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ('Alliqua' or 'the Company'), a provider of advanced wound care products, today announced plans to release third ...
About Alliqua Biomedical

Alliqua Biomedical logoAlliqua BioMedical, Inc. is a provider of advanced wound care solutions. The Company's businesses include advanced wound care and contract manufacturing. The Company operates through its subsidiaries, AquaMed Technologies, Inc. and Choice Therapeutics, Inc. The Company is engaged in developing a suite of advanced wound care solutions that will enable surgeons, clinicians and wound care practitioners to address the challenges in chronic and acute wounds. The Company utilizes hydrogel technology through which hydrogels are manufactured by introducing a hydrophilic polymer into water to create a feed mix. The Company's commercial wound care portfolio consists of four product categories: Human Biologics; Antimicrobial Protection; Exudate Management and Contract Manufacturing. Human Biologics include BIOVANCE and Extracellular Matrix (ECM). Under Antimicrobial Protection, the Company offers TheraBond 3D Antimicrobial Barrier Systems (TheraBond) and SilverSeal.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ALQA
  • CUSIP:
Key Metrics:
  • Previous Close: $1.13
  • 50 Day Moving Average: $1.12
  • 200 Day Moving Average: $1.26
  • P/E Ratio: N/A
  • P/E Growth: -0.09
  • Market Cap: $29.85M
  • Current Quarter EPS Consensus Estimate: $-0.89 EPS
Additional Links:
Alliqua Biomedical (NASDAQ:ALQA) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha